Nanocarrier system: An emerging strategy for bioactive peptide delivery
Open Access
- 5 December 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 1050647
Abstract
Compared with small-molecule synthetic drugs, bioactive peptides have desirable advantages in efficiency, selectivity, safety, tolerance, and side effects, which are accepted by attracting extensive attention from researchers in food, medicine, and other fields. However, unacceptable barriers, including mucus barrier, digestive enzyme barrier, and epithelial barrier, cause the weakening or the loss of bioavailability and biostability of bioactive peptides. The nanocarrier system for bioactive peptide delivery needs to be further probed. We provide a comprehensive update on the application of versatile delivery systems for embedding bioactive peptides, including liposomes, polymer nanoparticles, polysaccharides, hydrogels, and self-emulsifying delivery systems, and further clarify their structural characterization, advantages, and disadvantages as delivery systems. It aims to provide a reference for the maximum utilization of bioactive peptides. It is expected to be an effective strategy for improving the bioavailability and biostability of bioactive peptides.Keywords
This publication has 142 references indexed in Scilit:
- Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetesInternational Journal of Nanomedicine, 2013
- Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administrationEuropean Journal of Pharmaceutical Sciences, 2012
- Antihypertensive peptides from food proteins: a reviewFood & Function, 2012
- The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivoProceedings of the National Academy of Sciences, 2011
- Food applications of liposome-encapsulated antimicrobial peptidesTrends in Food Science & Technology, 2010
- Stability, liposome interaction, and in vivo pharmacology of ghrelin in liposomal suspensionsInternational Journal of Pharmaceutics, 2010
- Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: New system for sustained delivery of protein with a chaperone-like functionJournal of Controlled Release, 2010
- Polysaccharide nanogel delivery of a TNF-α and RANKL antagonist peptide allows systemic prevention of bone lossEuropean Journal of Pharmaceutical Sciences, 2009
- Evaluation of pharmacological efficacy of ‘insulin–surfoplex’ encapsulated polymer vesiclesInternational Journal of Pharmaceutics, 2009
- Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potentialJournal of Controlled Release, 1997